This page shows results related to Alaway and Flatulence from the FDA Adverse Event Reporting System (AERS). The adverse event Flatulence has been reported to the FDA a total of 2 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Flatulence is 2. The chart below compares this proportional reporting ratio of Flatulence for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Flatulence.
Flatulence | |
Alaway | 2 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Flatulence, why were they taking Alaway?
Eye Pruritus | 1 |
Lacrimation Increased | 1 |
Which medications reported to the FDA are most commonly associated with Flatulence?
Chantix | 1738 |
Alli | 1492 |
Byetta | 699 |
Pradaxa | 480 |
Sandostatin Lar | 465 |
Vioxx | 367 |
Lipitor | 354 |
Humira | 352 |
Nexium | 307 |
Fosamax | 303 |
Yaz | 269 |
Show More |